EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features

Shreya Gandhi, Beatriz Ocaña-Tienda, Manuel M Bettencourt, Olivia S Singh, Kaviya Devaraja iD, Emily R Irish, David Molina-García iD, Shirin Karimi, Yasin Mamatjan, Julio Sosa, Ian McIntyre, Andrew F Gao und 15 weitere

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 11.07.2026. Verfasst von Shreya Gandhi und 26 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Terry Fox Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GB) exhibits marked tumor microenvironmental heterogeneity, contributing to both therapy resistance and poor survival outcomes. Intercellular adhesion molecule 1 (ICAM1) is an inflammation-associated adhesion molecule implicated in immune-stromal interactions, but its clinical and biological significance in GB remains incompletely defined.

Methods

We performed ICAM1 immunohistochemistry, bulk RNA sequencing, DNA methylation analysis, single-nucleus RNA sequencing, and preoperative MRI-derived morphologic feature analysis across multi-institutional cohorts of treatment-naïve IDH-wildtype GB.

Results

High ICAM1 expression at both transcript and protein levels is associated with shorter overall survival, particularly within the mesenchymal transcriptional subtype. ICAM1 expression is inversely associated with promoter methylation. Single-nucleus RNA-sequencing analysis shows that ICAM1-high tumors are enriched for mesenchymal, hypoxia, stress-associated, and immunosuppressive myeloid programs, suggesting that ICAM1 reflects a multicompartment inflammatory tumor ecosystem. ICAM1 expression, tumor surface irregularity, and patient age are independently prognostic and minimally correlated, capturing complementary clinical, imaging, and molecular features of GB biology. When combined, our Clinical-Imaging-Molecular (CIM) framework refines outcome prediction across independent GB cohorts using routinely available clinical data, conventional imaging, and standard immunohistochemistry.

Conclusions

ICAM1 characterizes an immune-remodeled, stress-adapted GB ecosystem associated with poor clinical outcomes. Integrating patient age, surface irregularity, and ICAM1 expression yields a scalable and clinically accessible prognostic framework for GB, supporting tailored outcome prediction, particularly in low- and middle-resource settings without routine access to advanced molecular profiling.

Schlagwörter

Stichwörter der Autor:innen

ICAM1glioblastomamulti-omicsprognostictumor microenvironment

Autor:innen und Institutionen

  • Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Bioinformatics Unit, Spanish National Cancer Research Center, Madrid, Spain.
  • Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Mathematical Oncology Laboratory, University of Castilla-La Mancha, Ciudad Real, Spain.

ORCID-Profile: Kaviya Devaraja, David Molina-García, Julián Pérez-Beteta, Beatriz Asenjo, Pilar Sánchez-Gómez, Carlos Santos, Alireza Mansouri, Gelareh Zadeh, Sheila Mansouri

Förderung

  • Terry Fox Research Institute

Zitieren

APA

Gandhi, S., Ocaña-Tienda, B., Bettencourt, M. M., Singh, O. S., Devaraja, K., Irish, E. R., Molina-García, D., Karimi, S., Mamatjan, Y., Sosa, J., McIntyre, I., Gao, A. F., Pérez-Beteta, J., Ramos-González, A., Hernández-Laín, A., Asenjo, B., Flores-Rial, M. P., Sánchez-Gómez, P., Aldape, K. D., …, & Mansouri, S. (2026). Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag182

Vancouver

Gandhi S, Ocaña-Tienda B, Bettencourt MM, Singh OS, Devaraja K, Irish ER, et al. Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag182

BibTeX
@article{Gandhi2026,
  author = {Gandhi, Shreya and Ocaña-Tienda, Beatriz and Bettencourt, Manuel M and Singh, Olivia S and Devaraja, Kaviya and Irish, Emily R and Molina-García, David and Karimi, Shirin and Mamatjan, Yasin and Sosa, Julio and McIntyre, Ian and Gao, Andrew F and Pérez-Beteta, Julián and Ramos-González, Ana and Hernández-Laín, Aurelio and Asenjo, Beatriz and Flores-Rial, María Pino and Sánchez-Gómez, Pilar and Aldape, Kenneth D and Santos, Carlos and Drummond, Katharine J and Parney, Ian F and Velasquez, Carlos and Mansouri, Alireza and Pérez-García, Victor M and Zadeh, Gelareh and Mansouri, Sheila},
  title = {Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag182}
}
Kostenlos starten →